Pivotal Bio Venture Partners Investment Advisor LLC Io Biotech, Inc. Transaction History
Pivotal Bio Venture Partners Investment Advisor LLC
- $111 Million
- Q2 2024
A detailed history of Pivotal Bio Venture Partners Investment Advisor LLC transactions in Io Biotech, Inc. stock. As of the latest transaction made, Pivotal Bio Venture Partners Investment Advisor LLC holds 864,197 shares of IOBT stock, worth $916,048. This represents 0.91% of its overall portfolio holdings.
Number of Shares
864,197
Previous 864,197
-0.0%
Holding current value
$916,048
Previous $1.5 Million
32.37%
% of portfolio
0.91%
Previous 1.1%
Shares
1 transactions
Others Institutions Holding IOBT
# of Institutions
20Shares Held
25.9MCall Options Held
988KPut Options Held
0-
Vivo Capital, LLC Palo Alto, CA6.17MShares$6.54 Million1.07% of portfolio
-
Novo Holdings Hellerup, G74.43MShares$4.7 Million0.37% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.64MShares$3.86 Million2.19% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA2.34MShares$2.48 Million0.14% of portfolio
-
Marshall Wace, LLP London, X02.11MShares$2.23 Million0.0% of portfolio
About IO Biotech, Inc.
- Ticker IOBT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,815,300
- Market Cap $30.5M
- Description
- IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in ph...